Introduction: Electrophysiological (EEG) abnormalities in subjects with schizophrenia have
been largely reported. In the last decades, research has shifted to the identification of …

Cognitive dysfunctions represent a core feature of schizophrenia-spectrum disorders due to
their presence throughout different illness stages and their impact on functioning …

The reproducibility of machine-learning analyses in computational psychiatry is a growing
concern. In a multimodal neuropsychiatric dataset of antipsychotic-naïve, first-episode …

Mismatch negativity (MMN) is an auditory event‐related response reflecting the pre‐attentive
detection of novel stimuli and is a biomarker of cortical dysfunction in schizophrenia (SZ) …

The brain potential known as mismatch negativity (MMN) is one of the most studied indices
of altered brain function in schizophrenia. This review looks at what has been learned about …

Deficits in mismatch negativity (MMN) generation are among the best-established
biomarkers for cognitive dysfunction in schizophrenia and predict conversion to …

Both auditory evoked responses and metabolites measured by magnetic resonance
spectroscopy (MRS) are altered in schizophrenia and other psychotic disorders, but the …

We explored the neurophysiological activity underlying auditory novelty detection in
antipsychotic-naive patients with a first episode of psychosis (FEP). Fifteen patients with a …

Diagnosis, treatment, and prevention of mental illness requires brain-based biomarkers that
can serve as effective targets of evaluation. Here we target the neuroanatomically and …

Schizophrenia (SZ) is a complex and chronic psychotic disorder that affects approximately
1% of the world's population and is associated with positive, negative, and cognitive …